Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.74 USD | +5.45% | -2.79% | 0.00% |
Mar. 11 | Traders Anticipate Inflation Report as US Equities Open Lower on Wall Street | MT |
Mar. 11 | Top Premarket Gainers | MT |
Business Summary
Number of employees: 12
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Cini
FOU | Founder | 72 | 10-12-31 |
Pankaj Mohan
CEO | Chief Executive Officer | 60 | 20-03-31 |
Jay Cross
DFI | Director of Finance/CFO | 53 | 19-04-30 |
Manuel Dafonseca
CTO | Chief Tech/Sci/R&D Officer | - | 21-03-21 |
Richard Kenney
CTO | Chief Tech/Sci/R&D Officer | 66 | 21-03-31 |
Susan Dexter
CTO | Chief Tech/Sci/R&D Officer | 67 | 20-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Raghu Rao
BRD | Director/Board Member | 62 | 20-03-31 |
Pankaj Mohan
CEO | Chief Executive Officer | 60 | 20-03-31 |
Donald Griffith
BRD | Director/Board Member | 75 | 20-03-31 |
Albert Dyrness
BRD | Director/Board Member | 61 | 20-03-31 |
Nailesh Bhatt
BRD | Director/Board Member | 52 | 20-03-31 |
Lori McNeill
BRD | Director/Board Member | 51 | 22-09-24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,112,401 | 2,829,394 ( 90.91 %) | 0 | 90.91 % |
Company contact information
Sonnet BioTherapeutics Holdings, Inc.
100 Overlook Center Suite 102
08540, Princeton
+
http://www.sonnetbio.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 5.34M | |
+37.74% | 723B | |
+34.68% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+17.11% | 244B | |
+10.02% | 208B | |
-4.05% | 205B | |
+7.43% | 166B |
- Stock Market
- Equities
- SONN Stock
- Company Sonnet BioTherapeutics Holdings, Inc.